Clinical experience · Kratom and 7-OH dependence
MyStreetHealth treats kratom and 7-OH dependence as a clinical focus. The condition is real, the receptor pharmacology is well-described, and the treatment overlap with opioid use disorder is significant. Our team — led by a licensed physician — manages kratom and concentrated 7-OH dependence through telehealth visits in Virginia, West Virginia, Maryland, Washington DC, and Ohio, drawing on the published case-series literature (Wake Forest 2021, Yale 2024, Journal of Addiction Medicine case reports), FDA’s 2025 actions on concentrated 7-OH products (June 2025 warning letters; July 2025 scheduling recommendation), and our own clinical experience. Buprenorphine use for kratom or 7-OH dependence is off-label — the decision is individualized.
Why it works
Kratom acts on opioid receptors — so does buprenorphine.
Kratom's active compounds, including mitragynine and 7-hydroxymitragynine (7-OH), bind to mu-opioid receptors. Buprenorphine is a partial mu-opioid agonist with very high receptor affinity — it binds tightly to those same receptors and occupies them, which suppresses withdrawal and reduces the pull toward continued kratom use.
This is the same mechanism by which buprenorphine treats opioid use disorder from heroin, fentanyl, or prescription opioids. The receptor targets are the same.
What to expect
Withdrawal from kratom is real but manageable.
Kratom withdrawal typically includes muscle aches, irritability, insomnia, sweating, and strong cravings. The severity depends on how much kratom was used, how frequently, and for how long. 7-OH use tends to produce more intense withdrawal than high-dose kratom leaf products. Withdrawal is often more severe with concentrated products — see hydro 7 (7-OH) kratom.
Buprenorphine addresses most of these symptoms directly. Most patients feel meaningfully better within the first day of treatment. Induction timing varies — your physician will guide you on when to start based on your last kratom use and how you are feeling.
Evidence
Published case reports support buprenorphine for kratom withdrawal.
Multiple published case series and reports describe successful use of buprenorphine for kratom and 7-OH withdrawal. This is an evolving area — kratom dependence is increasingly recognized clinically, and the evidence base continues to grow. Buprenorphine is one of the medications that has been used in clinical settings for kratom and 7-OH dependence.
Treatment
Treatment is available through online visits.
MyStreetHealth treats kratom and 7-OH dependence through secure telehealth visits in Virginia, West Virginia, Maryland, Washington DC, and Ohio. No insurance required. Same-day visits usually available.
If you're planning a transition, see how to switch from kratom to Suboxone →